Your session is about to expire
← Back to Search
Other
Genetic Counseling Delivery Model for Metastatic Breast Cancer (EPOST MBC Trial)
N/A
Recruiting
Led By Lauren Nye, MD
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Have a diagnosis of human epidermal growth factor receptor 2 (HER2) negative metastatic breast cancer.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights
Summary
This trial will test a new way of delivering cancer genetic counseling to people with metastatic breast cancer who have been referred for such counseling and testing.
Who is the study for?
This trial is for individuals or their legal representatives who understand the study and consent to participate, speak English, have HER2-negative metastatic breast cancer, and are enrolled in the parent registry study. It excludes those with psychiatric conditions affecting compliance or who've had certain genetic tests after 2013.
What is being tested?
The trial is evaluating a new point of service delivery model for cancer genetics counseling in patients with metastatic breast cancer. The focus is on its effectiveness when patients receive referrals for hereditary cancer genetic counseling and testing.
What are the potential side effects?
Since this trial involves a service delivery model rather than a drug intervention, traditional side effects are not applicable. However, there may be psychological impacts from receiving genetic counseling which will be monitored.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My breast cancer is metastatic and HER2 negative.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Proportion of patients/participants that undergo hereditary cancer genetic testing after the telehealth intervention.
Secondary study objectives
Clinical decisional conflict score
Overall participant anxiety
Overall participant satisfaction
Trial Design
1Treatment groups
Experimental Treatment
Group I: Point of service delivery modelExperimental Treatment1 Intervention
After the informed consent is signed, the participant will watch a standardized video on the principles of genetic testing. At the end of the video, the provider will return to answer any remaining questions. The participant will receive pre- and post- surveys for evaluation of the delivery model.
Find a Location
Who is running the clinical trial?
University of Kansas Medical CenterLead Sponsor
488 Previous Clinical Trials
172,355 Total Patients Enrolled
22 Trials studying Breast Cancer
4,276 Patients Enrolled for Breast Cancer
Lauren Nye, MDPrincipal InvestigatorUniversity of Kansas
2 Previous Clinical Trials
14 Total Patients Enrolled
1 Trials studying Breast Cancer
11 Patients Enrolled for Breast Cancer
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had genetic testing for BRCA1 and BRCA2 mutations after 2013.I or my legal representative can understand the study and agree to sign the consent.My breast cancer is metastatic and HER2 negative.
Research Study Groups:
This trial has the following groups:- Group 1: Point of service delivery model
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger